Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation (HYBRID AF)

NCT04190186 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT04190186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04190186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hybrid Ablation Plus Medical Therapy for Persistent Atrial Fibrillation (HYBRID AF)
Lead sponsor
University of Rochester
Phase
Not applicable
Overall status
Completed
Start date
June 25, 2020
Completion date
February 15, 2024
Enrollment
55 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

persistent atrial fibrillation